Press Releases

DNA-based Skin Care Products Market Size to Worth Around USD 20.87 Bn by 2030

Share This Article

The global DNA-based Skin Care Products market size is expected to reach USD 20.87 billion by 2030, registering a CAGR of 10.5% over the forecast period 2021 – 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38497

Growth Factors

The beauty and personal care industry has witnessed steady growth with rising consumer spending. This trend is particularly true for the millennial population segment, which is fueled by the desire to slow down signs of aging. Aggressive advertising and promotional campaigns by niche and large players have also played a significant role in influencing consumer behavior. With the increasing inclination and ability to spend on beauty and cosmetic solutions, the market will continue to grow. Everyone’s skin is different, so instead of a generic approach from over-the-counter items, they need a regimen that is tailored to their own needs. Consumers are now being targeted more directly by skincare specialists, who are prescribing a customized range of products.

Report Coverage

Report Scope Details
Market Size USD 20.87 billion by 2030
Growth Rate CAGR of 10.5% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Product, Distribution Channel
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned IMAGENE LABS; EpigenCare; Caligenix; ALLÉL; SkinDNA; SKINSHIFT; ANAKE; Genetic Beauty; DNA Skin Institute; LifeNome

Report Highlights 

In terms of value, creams dominated the market with a share of over 50.0% in 2020. As the formulation comprises high-tech pharmaceutical active components, DNA-based skincare creams are touted as more than just aesthetic or cosmetics goods. They claim to preserve and even improve the skin’s function.

The offline distribution channel led the market and held a revenue share of over 65.0% in 2020.  The growth in offline sales is fueled by high preference among consumers for testing their genes at health and wellness clinics rather than doing the same using at-home kits. In DNA-based skin care products, the internet category is the fastest expanding. The pandemic has accelerated the shift in consumer behavior, with the increased adoption of do-it-yourself (DIY) content and an increase in online sales of beauty items. The trend is being driven by the younger workforce, internet penetration, and greater per capita consumption.

North America held the largest share of more than 35.0%. Consumer-driven, sustainable, and clean ingredient compositions are becoming increasingly popular in the cosmetics sector. With so many variables at play and so many established brands, the market for skincare products appears to be crowded.

Key Players

  • IMAGENE LABS
  • EpigenCare
  • Caligenix
  • ALLÉL
  • SkinDNA
  • SKINSHIFT
  • ANAKE
  • Genetic Beauty
  • DNA Skin Institute
  • LifeNome

Market Segmentation

  • Product
    • Creams
    • Serums
    • Others
  • Distribution Channel
    • Online
    • Offline
  • Regional
    • North America
      • U.S.
    • Europe
      • U.K.
      • Germany
    • Asia Pacific
      • China
      • India
    • Central & South America
      • Brazil
    • Middle East & Africa
      • Saudi Arabia

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38497

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global DNA-based Skin Care Products Market, By Product

7.1.  DNA-based Skin Care Products Market, by Product, 2021-2030

7.1.1.    Creams

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Serums

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Others

7.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global DNA-based Skin Care Products Market, By Distribution Channel

8.1.  DNA-based Skin Care Products Market, by Distribution Channel, 2021-2030

8.1.1.    Online

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Offline

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global DNA-based Skin Care Products Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Product (2017-2030)

9.1.2.    Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Product (2017-2030)

9.1.3.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Product (2017-2030)

9.1.4.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Product (2017-2030)

9.2.2.    Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Product (2017-2030)

9.2.3.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Product (2017-2030)

9.2.4.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Product (2017-2030)

9.2.5.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Product (2017-2030)

9.2.6.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Product (2017-2030)

9.3.2.    Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Product (2017-2030)

9.3.3.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Product (2017-2030)

9.3.4.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Product (2017-2030)

9.3.5.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Product (2017-2030)

9.3.6.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Product (2017-2030)

9.4.2.    Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Product (2017-2030)

9.4.3.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Product (2017-2030)

9.4.4.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Product (2017-2030)

9.4.5.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Product (2017-2030)

9.4.6.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Product (2017-2030)

9.5.2.    Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Product (2017-2030)

9.5.3.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Product (2017-2030)

9.5.4.2.        Market Revenue and Forecast, by Distribution Channel (2017-2030)

Chapter 10.  Company Profiles

10.1.              IMAGENE LABS

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              EpigenCare

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Caligenix

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              ALLÉL

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              SkinDNA

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              SKINSHIFT

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              ANAKE

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Genetic Beauty

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              DNA Skin Institute

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           LifeNome

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38497

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Show More

Related Articles

Back to top button